SynthesisPloS one2014

Patients with exon 19 deletion were associated with longer progression-free survival compared to those with L858R mutation after first-line EGFR-TKIs for advanced non-small cell lung cancer: a meta-analysis.

Yaxiong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.